HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter J Dickinson Selected Research

PTC-209

12/2022Expression and therapeutic targeting of BMI1 in canine gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter J Dickinson Research Topics

Disease

10Neoplasms (Cancer)
01/2021 - 04/2004
9Glioma (Gliomas)
12/2022 - 05/2010
3Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 05/2010
3Glioblastoma (Glioblastoma Multiforme)
08/2006 - 04/2004
2Brain Diseases (Brain Disorder)
04/2020 - 01/2013
2Meningioma (Meningiomas)
01/2019 - 02/2006
2Brain Neoplasms (Brain Tumor)
01/2019 - 01/2016
2Oligodendroglioma
01/2016 - 05/2010
2Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
12/2015 - 11/2005
1Retinoblastoma (Glioblastoma, Retinal)
12/2022
1Feline Infectious Peritonitis
07/2020
1Infections
01/2020
1COVID-19
01/2020
1Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
01/2018
1Leukoencephalopathies
01/2018
1Chromosome Aberrations (Chromosome Abnormalities)
01/2016
1Pain (Aches)
12/2012
1Cryptococcosis
08/2011
1Neoplasms by Histologic Type
03/2011
1Muscular Dystrophies (Muscular Dystrophy)
12/2008
1Wounds and Injuries (Trauma)
11/2008
1Disease Progression
05/2006
1Otitis Media
05/2006
1Blister (Bulla)
05/2006
1Myasthenia Gravis
11/2005

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
03/2020 - 09/2009
3Proteins (Proteins, Gene)FDA Link
12/2022 - 02/2006
2Antiviral Agents (Antivirals)IBA
07/2020 - 01/2020
2Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2015 - 11/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2006 - 05/2006
1PTC-209IBA
12/2022
1Ephrin-A1 (Ephrin A1)IBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2021
1EphA2 ReceptorIBA
01/2021
1EphrinsIBA
01/2021
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
01/2021
1Interleukin-13IBA
01/2021
1gamma-glutamylaminomethylsulfonic acid (GAMS)IBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1Phosphotransferases (Kinase)IBA
10/2020
1tyrosine receptor (receptor, tyrosine)IBA
10/2020
1Adenosine (Adenocard)FDA LinkGeneric
07/2020
1NucleosidesIBA
07/2020
1GS-441524IBA
07/2020
1MicroRNAs (MicroRNA)IBA
04/2020
1Biomarkers (Surrogate Marker)IBA
04/2020
1Caspase 3 (Caspase-3)IBA
01/2019
1NAD (NADH)IBA
01/2018
1Complement System Proteins (Complement)IBA
01/2016
1Thiamine (Aneurin)FDA Link
01/2013
1EndorphinsIBA
12/2012
1Hormones (Hormone)IBA
12/2012
1SteroidsIBA
12/2012
1AntigensIBA
08/2011
1Topoisomerase InhibitorsIBA
09/2010
1Irinotecan (Camptosar)FDA LinkGeneric
09/2010
1Platelet-Derived Growth Factor alpha ReceptorIBA
05/2010
1Dystroglycans (Dystroglycan)IBA
12/2008
1Capsid Proteins (Capsid Protein)IBA
08/2006
1Pharmaceutical PreparationsIBA
05/2006
1Anti-Bacterial Agents (Antibiotics)IBA
05/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2006
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
05/2006
1GlucocorticoidsIBA
02/2006
1Cholinergic ReceptorsIBA
11/2005
1Edrophonium (Tensilon)FDA LinkGeneric
11/2005
1AntibodiesIBA
11/2005
11- (2- (9- octadecenoyloxy)ethyl)- 2- (8- heptadecenyl)- 3- (hydroxyethyl)imidazoliniumIBA
04/2004
1CytokinesIBA
04/2004
1Liposomes (Liposome)IBA
04/2004
1DNA (Deoxyribonucleic Acid)IBA
04/2004
1LipidsIBA
04/2004
1CholesterolIBA
04/2004

Therapy/Procedure

5Therapeutics
01/2019 - 05/2006
1Drug Therapy (Chemotherapy)
01/2016
1Nerve Block (Nerve Blocks)
11/2008
1Osteotomy
05/2006